Metric Finance
LearnFAQ
LearnFAQ

Learn / ACHV

NASDAQ: ACHV

Achieve Life Sciences (ACHV) stock, explained like you're 5

Achieve Life Sciences trades on the Nasdaq under the ticker ACHV. It is a small cap company in the in vitro & in vivo diagnostic substances industry, part of the healthcare sector, with a market value of about 763 million dollars.

Ticker
ACHV
Exchange
Nasdaq
Sector
Healthcare
Industry
In Vitro & In Vivo Diagnostic Substances
Size
Small cap, about 763 million dollars

Is Achieve Life Sciences a small, medium or large cap company?

No. Achieve Life Sciences is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 763 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Achieve Life Sciences makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ACHV stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Achieve Life Sciences (NASDAQ:ACHV) Stock Falls 6% Should You Sell? (MarketBeat)
  • Achieve's Cytisinicline Study Finds 24.4% Abstinence vs. 15.8% Placebo (Stock Titan)
  • EX 99.1 SEC.gov (SEC.gov)
  • Achieve Life Sciences (NasdaqCM:ACHV) Stock Forecast & Analyst Predictions (Simply Wall Street)
  • Achieve Life Sciences, Inc. (ACHV) What Are Investment Firms Saying About This Stock? (MarketBeat)

Follow ACHV in your daily brief

Each trading day at 5 PM ET we post what happened to Achieve Life Sciences and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ACHV

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Achieve Life Sciences stock

What does Achieve Life Sciences do?

Achieve Life Sciences trades on the Nasdaq under the ticker ACHV. It is a small cap company in the in vitro & in vivo diagnostic substances industry, part of the healthcare sector, with a market value of about 763 million dollars.

What is the ticker symbol for Achieve Life Sciences?

Achieve Life Sciences trades under the ticker ACHV on the Nasdaq.

What is Achieve Life Sciences's market cap?

Achieve Life Sciences is a small cap stock with a market cap of about 763 million dollars.

How does Achieve Life Sciences make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ACHV stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ACHV stock every day?

Add ACHV to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ACHV daily

A free brief on Achieve Life Sciences and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • LNTH · Lantheus Holdings
  • ORKA · Oruka Therapeutics
  • NEOG · Neogen
  • CLDX · Celldex Therapeutics

Similar stocks

  • LNTHLantheus Holdings
  • ORKAOruka Therapeutics
  • NEOGNeogen
  • CLDXCelldex Therapeutics

Compare ACHV: ACHV vs LNTH, ACHV vs ORKA, ACHV vs NEOG

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed